Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Medtronic (NY:MDT)

87.59 -0.90 (-1.02%)
Streaming Delayed Price Updated: 9:55 AM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
49 50 Next >
Universal Adhesive Patch For CGM And Insulin Pump
Via AB Newswire
Looking Into Medtronic's Recent Short Interest
Via Benzinga
3 Reasons Medtronic's Stock Can Continue Rallying Higher
Medtronic's stock has been rising higher in recent weeks after another solid quarterly performance. 
Via The Motley Fool
3M, Visa, Medtronic And More On CNBC's 'Final Trades'
Joshua Brown of Ritholtz Wealth Management named 3M Co. as his final trade on CNBC's Halftime Report, while other experts shared picks like Visa and Medtronic. 
Via Benzinga
Medtronic Stock: Growth On Rise of the Cardiovascular Machines
Medtronic is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases 
Via MarketBeat
Medtronic Recalls Some Video Laryngoscopes Due To Increased Risk For Battery Overheat, Explosion
Medtronic recalls devices over battery risks that could lead to explosions and updates usage instructions. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Is Medtronic Stock a Buy?
It might not be the most exciting business, but it has other things going its way. 
Via The Motley Fool
Medtronic Analysts Boost Their Forecasts After Upbeat Earnings
Via Benzinga
Billionaire Ray Dalio's Former Hedge Fund Is Buying These 3 Top Dividend Stocks. Should You?
Bridgewater Associates is loading up on shares of ExxonMobil, Medtronic, and Microsoft. Here's what you need to know. 
Via The Motley Fool
MarketBeat Week in Review – 8/26 - 8/30
The major indexes moved between gains and losses to end the month, but the volatility may ramp back up with the release of the jobs report next Friday 
Via MarketBeat
This Is Great News for Medtronic, but Is It Time to Buy the Stock?
This MedTech leader is back on track with profitable growth. 
Via The Motley Fool
Stock Market Rallies As Powell Confirms Rate Cuts; Palo Alto, Cava, Target Jump: Weekly Review
Palo Alto and Cava were among the earnings winners. 
Via Investor's Business Daily
Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally
Medtronic's Q1 FY2025 results were driven by its diabetes products, and new offerings in development or pending FDA approval could fuel future performance. 
Via MarketBeat
Exposures Product Safety
Texas Instruments To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Medtronic (MDT) Q1 2025 Earnings Call Transcript
MDT earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Wall Street Eases, Bonds Rises, US Dollar Falls To 8-Month Low: What's Driving Markets Tuesday?
It’s a relatively uneventful session on Wall Street, but with a slightly worsening risk sentiment as all U.S. equity indices traded in the red at around midday trading in New York. 
Via Benzinga
Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings
Via Benzinga
MDT Stock Earnings: Medtronic Beats EPS, Beats Revenue for Q1 2025
MDT stock results show that Medtronic beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2025. 
Via InvestorPlace
Medical Devices Giant Medtronic Q1 Earnings: Revenue And EPS Beat, Lifts Annual Guidance Marginally On Sustained Growth From New Product Launches
Medtronic beats Q1 2025 earnings and revenue estimates with $7.9 billion in sales, driven by growth in Cardiac, Neuromodulation, and Diabetes segments. The company raises FY25 guidance, citing strong... 
Via Benzinga
Medtronic Posts Modest Beat-And-Raise Report For Fiscal First Quarter
Medtronic stock rose early Tuesday after the medtech company reported slightly better-than-expected results for its fiscal first quarter. 
Via Investor's Business Daily
US Stocks May Take a Breather After S&P 500's Impressive 8-Session Winning Streak: Strategist Says Market Will Hit Fresh Highs In Next 4 Weeks, But Warns Investors Of Potential Risks
The gravity-defying climb faces risk, as the index futures trade narrowly mixed in early trading on Tuesday. That said, the recent gains could keep traders wary of a potential pullback. 
Via Benzinga
Topics Stocks
Exposures US Equities
S&P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Lowe's, Palo Alto Networks And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
5 Dividend Growth Stocks to Buy and Hold Forever
Dividend growth stocks offer investors a powerful combination of income and capital appreciation potential, making them attractive for long-term portfolios. 
Via The Motley Fool
3 Dividend Stocks to Double Up On Right Now
How does a 5.7% dividend yield sound? 
Via The Motley Fool
Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
7 Defensive Stocks to Buy as Investors Seek Shelter
With the market primed for more jitters, investors should consider battening down the hatches with these defensive stocks. 
Via InvestorPlace
TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?
Surgical robotics company PROCEPT BioRobotics Co. (NASDAQ: PRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia 
Via MarketBeat
Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108?
An unexpected diabetes partnership with Medtronic bodes well for Abbott's biggest growth driver. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.